Rosuvastatin Augments Dipyridamole Induced Vasodilation by Increased Adenosine Receptor Stimulation.
Phase of Trial: Phase IV
Latest Information Update: 04 Apr 2012
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Hyperlipidaemia
- Focus Pharmacodynamics
- 01 Jun 2009 Results published in Arteriosclerosis Thrombosis and Vascular Biology.
- 22 Sep 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 20 Nov 2007 New trial record.